Literature DB >> 22543530

Circadian rhythms in obsessive-compulsive disorder.

Klaus W Lange1, Katharina M Lange, Joachim Hauser, Lara Tucha, Oliver Tucha.   

Abstract

The etiopathology and neurobiology of obsessive-compulsive disorder (OCD) are not fully understood. As for altered circadian rhythms associated with OCD, hormonal dysregulation and a delayed sleep phase have come into the focus of research. The novel antidepressant agomelatine is able to resynchronize circadian rhythms and the augmentative administration of this compound has been shown to be of benefit in some OCD patients who are refractory to common forms of pharmacotherapy. Adjunctive chronotherapy might also enhance the outcome in treatment-refractory OCD. The present review summarises the findings regarding circadian abnormalities in OCD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543530     DOI: 10.1007/s00702-012-0805-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  82 in total

Review 1.  Stress and the brain: from adaptation to disease.

Authors:  E Ron de Kloet; Marian Joëls; Florian Holsboer
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

2.  High prevalence of personality disorders among circadian rhythm sleep disorders (CRSD) patients.

Authors:  Y Dagan; H Sela; H Omer; D Hallis; R Dar
Journal:  J Psychosom Res       Date:  1996-10       Impact factor: 3.006

Review 3.  Genetics of early-onset obsessive-compulsive disorder.

Authors:  Susanne Walitza; Jens R Wendland; Edna Gruenblatt; Andreas Warnke; Thomas A Sontag; Oliver Tucha; Klaus W Lange
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-06       Impact factor: 4.785

4.  Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults.

Authors:  T J Fabian; M A Dew; B G Pollock; C F Reynolds; B H Mulsant; M A Butters; M D Zmuda; A M Linares; M Trottini; P D Kroboth
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

5.  Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.

Authors:  Daniela Eser; Cornelius Schüle; Elena Romeo; Thomas C Baghai; Flavia di Michele; Augusto Pasini; Peter Zwanzger; Frank Padberg; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

Review 6.  The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.

Authors:  G M Sullivan; J D Coplan; J M Kent; J M Gorman
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 7.  Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease.

Authors:  Katharina Wulff; Silvia Gatti; Joseph G Wettstein; Russell G Foster
Journal:  Nat Rev Neurosci       Date:  2010-07-14       Impact factor: 34.870

8.  Frequency of obsessive-compulsive disorder in a community sample of young adolescents.

Authors:  L A Valleni-Basile; C Z Garrison; K L Jackson; J L Waller; R E McKeown; C L Addy; S P Cuffe
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

9.  Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder.

Authors:  F Catapano; P Monteleone; A Fuschino; M Maj; D Kemali
Journal:  Psychiatry Res       Date:  1992-12       Impact factor: 3.222

10.  The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group.

Authors:  M M Weissman; R C Bland; G J Canino; S Greenwald; H G Hwu; C K Lee; S C Newman; M A Oakley-Browne; M Rubio-Stipec; P J Wickramaratne
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

View more
  3 in total

1.  Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.

Authors:  Maria S Signorelli; Carmen Concerto; Eliana Battaglia; Maria C Costanzo; Fortunato Battaglia; Eugenio Aguglia
Journal:  SAGE Open Med Case Rep       Date:  2014-12-04

2.  Delayed sleep timing and circadian rhythms in pregnancy and transdiagnostic symptoms associated with postpartum depression.

Authors:  Jessica L Obeysekare; Zachary L Cohen; Meredith E Coles; Teri B Pearlstein; Carmen Monzon; E Ellen Flynn; Katherine M Sharkey
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

3.  Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report.

Authors:  Domenico De Berardis; Nicola Serroni; Stefano Marini; Giovanni Martinotti; Francesca Ferri; Gaetano Callista; Raffaella La Rovere; Francesco Saverio Moschetta; Massimo Di Giannantonio
Journal:  Case Rep Psychiatry       Date:  2012-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.